10-68465747-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001080449.3(DNA2):​c.507C>A​(p.Ala169Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 1,604,186 control chromosomes in the GnomAD database, including 50,571 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 7304 hom., cov: 32)
Exomes 𝑓: 0.23 ( 43267 hom. )

Consequence

DNA2
NM_001080449.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.314

Publications

25 publications found
Variant links:
Genes affected
DNA2 (HGNC:2939): (DNA replication helicase/nuclease 2) This gene encodes a member of the DNA2/NAM7 helicase family. The encoded protein is a conserved helicase/nuclease involved in the maintenance of mitochondrial and nuclear DNA stability. Mutations in this gene are associated with autosomal dominant progressive external ophthalmoplegia-6 (PEOA6) and Seckel syndrome 8. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
DNA2 Gene-Disease associations (from GenCC):
  • mitochondrial DNA deletion syndrome with progressive myopathy
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • Seckel syndrome 8
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 10-68465747-G-T is Benign according to our data. Variant chr10-68465747-G-T is described in ClinVar as Benign. ClinVar VariationId is 257346.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.314 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.418 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001080449.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNA2
NM_001080449.3
MANE Select
c.507C>Ap.Ala169Ala
synonymous
Exon 4 of 21NP_001073918.2
DNA2
NR_102264.2
n.596C>A
non_coding_transcript_exon
Exon 5 of 22

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNA2
ENST00000358410.8
TSL:1 MANE Select
c.507C>Ap.Ala169Ala
synonymous
Exon 4 of 21ENSP00000351185.3
DNA2
ENST00000551118.6
TSL:5
c.507C>Ap.Ala169Ala
synonymous
Exon 4 of 17ENSP00000450393.3
DNA2
ENST00000399179.6
TSL:2
n.507C>A
non_coding_transcript_exon
Exon 5 of 22ENSP00000382132.3

Frequencies

GnomAD3 genomes
AF:
0.295
AC:
44735
AN:
151842
Hom.:
7276
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.423
Gnomad AMI
AF:
0.220
Gnomad AMR
AF:
0.301
Gnomad ASJ
AF:
0.220
Gnomad EAS
AF:
0.395
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.277
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.296
GnomAD2 exomes
AF:
0.280
AC:
68446
AN:
244024
AF XY:
0.276
show subpopulations
Gnomad AFR exome
AF:
0.423
Gnomad AMR exome
AF:
0.354
Gnomad ASJ exome
AF:
0.220
Gnomad EAS exome
AF:
0.391
Gnomad FIN exome
AF:
0.272
Gnomad NFE exome
AF:
0.205
Gnomad OTH exome
AF:
0.273
GnomAD4 exome
AF:
0.233
AC:
338821
AN:
1452228
Hom.:
43267
Cov.:
31
AF XY:
0.237
AC XY:
171032
AN XY:
722098
show subpopulations
African (AFR)
AF:
0.424
AC:
14020
AN:
33104
American (AMR)
AF:
0.348
AC:
15143
AN:
43478
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
5577
AN:
25872
East Asian (EAS)
AF:
0.418
AC:
16492
AN:
39428
South Asian (SAS)
AF:
0.373
AC:
31320
AN:
84054
European-Finnish (FIN)
AF:
0.270
AC:
14378
AN:
53158
Middle Eastern (MID)
AF:
0.331
AC:
1897
AN:
5728
European-Non Finnish (NFE)
AF:
0.203
AC:
224801
AN:
1107492
Other (OTH)
AF:
0.254
AC:
15193
AN:
59914
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
11395
22790
34186
45581
56976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8208
16416
24624
32832
41040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.295
AC:
44823
AN:
151958
Hom.:
7304
Cov.:
32
AF XY:
0.296
AC XY:
22008
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.424
AC:
17551
AN:
41424
American (AMR)
AF:
0.301
AC:
4593
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
764
AN:
3470
East Asian (EAS)
AF:
0.395
AC:
2043
AN:
5168
South Asian (SAS)
AF:
0.381
AC:
1838
AN:
4822
European-Finnish (FIN)
AF:
0.275
AC:
2909
AN:
10566
Middle Eastern (MID)
AF:
0.277
AC:
81
AN:
292
European-Non Finnish (NFE)
AF:
0.209
AC:
14216
AN:
67964
Other (OTH)
AF:
0.299
AC:
627
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1550
3100
4649
6199
7749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.227
Hom.:
4568
Bravo
AF:
0.305
Asia WGS
AF:
0.373
AC:
1295
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 22, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Seckel syndrome 8 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mitochondrial DNA deletion syndrome with progressive myopathy Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.1
DANN
Benign
0.73
PhyloP100
-0.31
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3758626; hg19: chr10-70225504; COSMIC: COSV63063099; COSMIC: COSV63063099; API